Charles Robert Horsburgh
#143,222
Most Influential Person Now
Researcher
Charles Robert Horsburgh's AcademicInfluence.com Rankings
Charles Robert Horsburghengineering Degrees
Engineering
#5466
World Rank
#6725
Historical Rank
Electrical Engineering
#1523
World Rank
#1617
Historical Rank
Charles Robert Horsburghcomputer-science Degrees
Computer Science
#7005
World Rank
#7378
Historical Rank
Computational Linguistics
#1320
World Rank
#1335
Historical Rank
Machine Learning
#2452
World Rank
#2484
Historical Rank
Artificial Intelligence
#2736
World Rank
#2779
Historical Rank
Download Badge
Engineering Computer Science
Charles Robert Horsburgh's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Charles Robert Horsburgh Influential?
(Suggest an Edit or Addition)Charles Robert Horsburgh's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Three months of rifapentine and isoniazid for latent tuberculosis infection. (2011) (772)
- Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. (1993) (745)
- Priorities for the treatment of latent tuberculosis infection in the United States. (2004) (617)
- Accelerated course of human immunodeficiency virus infection after tuberculosis. (1995) (593)
- The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. (2017) (447)
- The resurgence of tuberculosis: is your laboratory ready? (1993) (391)
- Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial (2002) (386)
- Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. (2012) (316)
- DURATION OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION BEFORE DETECTION OF ANTIBODY (1989) (287)
- Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. (1991) (284)
- Disseminated Infection with Mycobacterium avium‐intracellulare: A REPORT OF 13 CASES AND A REVIEW OF THE LITERATURE (1985) (255)
- Emergence of Buruli ulcer disease in the Daloa region of Cote d'Ivoire. (1995) (233)
- Clinical practice. Latent tuberculosis infection in the United States. (2011) (233)
- Evaluation of exposure-specific risks from two independent samples: A simulation study (2011) (233)
- Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline (2019) (216)
- Prevention of tuberculosis in Bacille Calmette–Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine (2010) (214)
- High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. (2005) (206)
- Endothelial function in HIV-infected persons. (2006) (205)
- High Incidence of Hospital Admissions With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Among South African Health Care Workers (2010) (204)
- Latent TB infection treatment acceptance and completion in the United States and Canada. (2010) (202)
- Infectiousness of HIV between male homosexual partners. (1989) (198)
- Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy. (1991) (198)
- Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 (2020) (189)
- The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). (1989) (187)
- Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. (1992) (172)
- Lack of weight gain and relapse risk in a large tuberculosis treatment trial. (2006) (167)
- Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends. (1992) (164)
- Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup. (2013) (161)
- Priorities for screening and treatment of latent tuberculosis infection in the United States. (2011) (151)
- Noninvasive Markers of Liver Fibrosis Are Highly Predictive of Liver-Related Death in a Cohort of HCV-Infected Individuals With and Without HIV Infection (2010) (144)
- Revisiting rates of reactivation tuberculosis: a population-based approach. (2010) (135)
- Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection. (1994) (134)
- Practice guidelines for the treatment of tuberculosis. (2000) (132)
- Mycobacterium avium complex in water, food, and soil samples collected from the environment of HIV-infected individuals. (1995) (123)
- The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients--a prospective study. (1994) (123)
- Use of a population-based survey to describe the health of Boston public housing residents. (2008) (122)
- A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex. (1999) (116)
- Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection (2013) (115)
- Treatment of Tuberculosis. (2015) (115)
- Seroconversion to human immunodeficiency virus in prison inmates. (1990) (115)
- HIV Infection Does Not Affect the Performance of Noninvasive Markers of Fibrosis for the Diagnosis of Hepatitis C Virus-Related Liver Disease (2005) (111)
- Biologic factors in the sexual transmission of human immunodeficiency virus. (1989) (110)
- Acquired immunodeficiency syndrome in a patient with hemophilia. (1983) (109)
- The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection (2015) (107)
- The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis (2020) (104)
- Healing by design. (1995) (102)
- Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. (2001) (102)
- Environmental risk factors for infection with Mycobacterium avium complex. (2006) (98)
- Emergence of a unique group of necrotizing mycobacterial diseases. (1999) (98)
- Pathology of emerging infections (1997) (93)
- Predicting non-completion of treatment for latent tuberculous infection: a prospective survey. (2006) (92)
- The pathophysiology of disseminated Mycobacterium avium complex disease in AIDS. (1999) (85)
- The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis (2012) (85)
- Health-related quality of life of patients with HIV disease: impact of hepatitis C coinfection. (2004) (85)
- Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985-2000. (2001) (84)
- The relation between nitrite inhalants, unprotected receptive anal intercourse, and the risk of human immunodeficiency virus infection. (1992) (82)
- Pathologic findings in disseminated Mycobacterium avium-intracellulare infection. A report of 11 cases. (1986) (81)
- Site of disease and opportunistic infection predict survival in HIV‐associated tuberculosis (1997) (77)
- Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing. (2015) (76)
- The scope and impact of treatment of latent tuberculosis infection in the United States and Canada. (2006) (76)
- Diabetes, Glycemic Control, and Risk of Tuberculosis (2011) (72)
- Management of drug-resistant tuberculosis (2019) (70)
- Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease. (1993) (69)
- A Prospective Randomized Trial of Four Three-Drug Regimens in the Treatment of Disseminated Mycobacterium avium Complex Disease in AIDS Patients: Excess Mortality Associated with High-Dose Clarithromycin (1999) (69)
- Environmental risk factors for acquisition of Mycobacterium avium complex in persons with human immunodeficiency virus infection. (1994) (69)
- Predictors of survival in patients with AIDS and disseminated Mycobacterium avium complex disease. (1994) (68)
- Sources of disseminated Mycobacterium avium infection in AIDS. (2002) (68)
- Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosis. (1998) (67)
- Risk factors for postoperative pneumonia after lung cancer surgery and impact of pneumonia on survival. (2015) (66)
- Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings (2018) (65)
- Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndrome (1986) (65)
- Hospital water as a source of Mycobacterium avium complex isolates in respiratory specimens. (2004) (65)
- The associations of binge alcohol use with HIV/STI risk and diagnosis among heterosexual African American men. (2009) (65)
- Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis. (1999) (64)
- Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa. (2009) (64)
- Principles for designing future regimens for multidrug-resistant tuberculosis. (2014) (64)
- Predictors of failure to complete treatment for latent tuberculosis infection. (2007) (63)
- Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapy. (2003) (61)
- Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans. (2014) (60)
- A comparison of HIV-1 antibody classes, titers, and specificities in paired semen and blood samples from HIV-1 seropositive men. (1992) (59)
- Undernutrition and Tuberculosis: Public Health Implications. (2018) (57)
- Prevention of tuberculosis in older adults in the United States: obstacles and opportunities. (2013) (57)
- The global distribution of human immunodeficiency virus type 2 (HIV‐2) infection (1988) (55)
- Disseminated tuberculosis in human immunodeficiency virus infection: ineffective immunity, polyclonal disease and high mortality. (2011) (55)
- Serologic response to culture filtrate antigens of Mycobacterium ulcerans during Buruli ulcer disease. (2000) (55)
- Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection? (1991) (53)
- Adherence in the Treatment of Patients With Extensively Drug-Resistant Tuberculosis and HIV in South Africa: A Prospective Cohort Study (2014) (53)
- Latent tuberculous infection in the United States and Canada: who completes treatment and why? (2015) (51)
- Advances in the prevention and treatment of Mycobacterium avium disease. (1996) (50)
- Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model (2017) (50)
- Changes in the Spectrum of AIDS‐Defining Conditions and Decrease in CD4+ Lymphocyte Counts at AIDS Manifestation in Germany from 1986 to 1991 (1992) (50)
- Epidemiology of mycobacterial diseases in AIDS. (1992) (49)
- Paediatric tuberculosis transmission outside the household: challenging historical paradigms to inform future public health strategies. (2019) (48)
- The global problem of multidrug-resistant tuberculosis: the genie is out of the bottle. (2000) (46)
- Existing blood transcriptional classifiers accurately discriminate active tuberculosis from latent infection in individuals from south India. (2018) (46)
- A pilot study of treatment of Buruli ulcer with rifampin and dapsone. (2002) (46)
- Early manifestations of disseminated Mycobacterium avium complex disease: a prospective evaluation. (1997) (46)
- Recent drug use, homelessness and increased short-term mortality in HIV-infected persons with alcohol problems (2008) (45)
- Survival prognosis of HIV-infected patients. (1993) (44)
- Epidemiology of disease caused by nontuberculous mycobacteria. (1996) (43)
- Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania. (2010) (43)
- Basis for treatment of tuberculosis among HIV-infected patients in Tanzania: the role of chest x-ray and sputum culture (2008) (39)
- Comparison of four decontamination methods for recovery of Mycobacterium avium complex from stools (1993) (39)
- One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. (2019) (38)
- Preventive strategies in sexually transmitted diseases for the primary care physician. US Preventive Services Task Force. (1987) (38)
- A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS. (1999) (37)
- Hepatic inflammation, hepatitis B replication, and cellular immune function in homosexual males with chronic hepatitis B and antibody to human immunodeficiency virus. (1988) (37)
- A prospective evaluation of Mycobacterium avium complex colonization of the respiratory and gastrointestinal tracts of persons with human immunodeficiency virus infection. (1993) (37)
- Protection from Mycobacterium avium complex disease in human immunodeficiency virus-infected persons with a history of tuberculosis. (1996) (36)
- Risk factors for nonadherence with Pap testing in HIV-infected women. (2011) (35)
- Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa (2016) (35)
- Recurrent tuberculosis risk among HIV-infected adults in Tanzania with prior active tuberculosis. (2013) (34)
- Corroboration of sexual histories among male homosexual couples. (1992) (34)
- Cellular Immune Responses to ESAT-6 Discriminate between Patients with Pulmonary Disease Due to Mycobacterium avium Complex and Those with Pulmonary Disease Due toMycobacterium tuberculosis (1999) (34)
- The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis. (2020) (34)
- Acceptance of treatment for latent tuberculosis infection: prospective cohort study in the United States and Canada. (2013) (32)
- Tuberculosis and risk of cancer: a Danish nationwide cohort study. (2014) (32)
- Comorbidities in pulmonary tuberculosis cases in Puducherry and Tamil Nadu, India: Opportunities for intervention (2017) (31)
- Risk of progression to active tuberculosis among foreign-born persons with latent tuberculosis. (2007) (30)
- Increased risk of active tuberculosis after cancer diagnosis. (2017) (30)
- Recent cigarette smoking and HIV disease progression: no evidence of an association (2011) (30)
- Preventing disseminated Mycobacterium avium complex disease in patients infected with human immunodeficiency virus. (1995) (29)
- The bone marrow in disseminated Mycobacterium avium-intracellulare infection. (1985) (29)
- Compassionate use of and expanded access to new drugs for drug-resistant tuberculosis. (2013) (29)
- Predictors of delayed care seeking for tuberculosis in southern India: an observational study (2017) (29)
- Quantifying TB transmission: a systematic review of reproduction number and serial interval estimates for tuberculosis (2018) (29)
- Experiences of Racial Discrimination and Relation to Sexual Risk for HIV among a Sample of Urban Black and African American Men (2013) (28)
- Risk of human immunodeficiency virus infection from unprotected receptive anal intercourse increases with decline in immunologic status of infected partners. (1993) (28)
- Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study. (2019) (28)
- Predicting Mycobacterium avium complex bacteremia in patients infected with human immunodeficiency virus: a prospectively validated model. (1994) (28)
- Concordance of polymerase chain reaction with human immunodeficiency virus antibody detection. (1990) (27)
- Effect of malnutrition on radiographic findings and mycobacterial burden in pulmonary tuberculosis (2019) (27)
- Lack of evidence of prolonged human immunodeficiency virus infection before antibody seroconversion. (1988) (27)
- Adolescent Experiences of Violence and Relation to Violence Perpetration beyond Young Adulthood among an Urban Sample of Black and African American Males (2014) (27)
- Human immunodeficiency virus infection in a rural community in the United States. (2004) (27)
- Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis. (2010) (26)
- Epidemiology of Mycobacterium avium Complex Disease (1997) (26)
- Altered excretion of modified nucleosides and beta-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndrome. (1986) (25)
- Risk of Cryptosporidium parvum transmission between hospital roommates. (2000) (24)
- Impact of alcohol consumption on tuberculosis treatment outcomes: a prospective longitudinal cohort study protocol (2018) (24)
- The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients (2014) (23)
- Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis. (2022) (21)
- Detection, survival and infectious potential of Mycobacterium tuberculosis in the environment: a review of the evidence and epidemiological implications (2019) (21)
- Interaction of nutritional status and diabetes on active and latent tuberculosis: a cross-sectional analysis (2019) (20)
- Epidemiology of tuberculosis in the era of HIV. (1993) (20)
- Integration of a participatory research strategy into a rural health survey (2003) (20)
- Increased suppressor T cells in probable transmitters of human immunodeficiency virus infection. (1989) (18)
- Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfection. (2011) (18)
- Relationship Between Hepatitis C Clinical Testing Site and Linkage to Care (2014) (18)
- Increased Doses Lead to Higher Drug Exposures of Levofloxacin for Treatment of Tuberculosis (2018) (18)
- Using Resident Health Advocates to Improve Public Health Screening and Follow-Up Among Public Housing Residents, Boston, 2007-2008 (2010) (18)
- Genetic similarity among Mycobacterium avium isolates from blood, stool, and sputum of persons with AIDS. (1997) (17)
- Can patients afford the cost of treatment for multidrug-resistant tuberculosis in Ethiopia? (2018) (17)
- Extensively Drug-Resistant Tuberculosis in Women, KwaZulu-Natal, South Africa (2011) (17)
- Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults. (2016) (17)
- An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial (2017) (17)
- The significance of antilymphocyte antibodies in patients with acquired immune deficiency syndrome (AIDS) and their sexual partners (1987) (17)
- Guidelines for the treatment of latent tuberculosis infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 (2020) (17)
- Randomized clinical trials to identify optimal antibiotic treatment duration (2013) (16)
- History of incarceration and gang involvement are associated with recent sexually transmitted disease/HIV diagnosis in African American men. (2008) (16)
- The acquired immunodeficiency syndrome and a trimethoprim-sulfamethoxazole adverse reaction. (1984) (16)
- Tuberculosis without tubercles. (1996) (15)
- Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guérin during childhood and entering a tuberculosis booster vaccine trial. (2007) (15)
- Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunities. (2017) (15)
- Epidemiology of disseminated nontuberculous mycobacterial disease in children with acquired immunodeficiency syndrome. (1993) (15)
- Racial disparities in primary and reactivation tuberculosis in a rural community in the southeastern United States. (2010) (15)
- DAR-901 vaccine for the prevention of infection with Mycobacterium tuberculosis among BCG-immunized adolescents in Tanzania: A randomized controlled, double-blind phase 2b trial. (2020) (15)
- Developing a predictive risk model for first-line antiretroviral therapy failure in South Africa (2016) (15)
- Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset. (2019) (14)
- Issues in design and interpretation of MDR-TB clinical trials: report of the first Global MDR-TB Clinical Trials Landscape Meeting (2015) (14)
- Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania. (2011) (14)
- Pan-tuberculosis regimens: an argument against. (2018) (14)
- Geographic and seasonal variation in Mycobacterium avium bacteremia among North American patients with AIDS. (1997) (14)
- Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1 (2016) (14)
- The GirlStars Program: Challenges to Recruitment and Retention in a Physical Activity and Health Education Program for Adolescent Girls Living in Public Housing (2010) (14)
- Factors associated with loss to follow-up in a large tuberculosis treatment trial (TBTC Study 22). (2007) (14)
- Polyantigenic Interferon-γ Responses Are Associated with Protection from TB among HIV-Infected Adults with Childhood BCG Immunization (2011) (13)
- Molecular Epidemiology of HIV-Associated Tuberculosis in Dar es Salaam, Tanzania: Strain Predominance, Clustering, and Polyclonal Disease (2012) (13)
- Dual skin tests with Mycobacterium avium sensitin and PPD to detect misdiagnosis of latent tuberculosis infection. (2011) (12)
- Factors Influencing the Risk of Infection with Human Immunodeficiency Virus in Homosexual Men, Denver 1982–1985 (1989) (11)
- Increased mortality associated with treated active tuberculosis in HIV-infected adults in Tanzania. (2013) (11)
- FDG-PET/CT activity leads to the diagnosis of unsuspected TB: a retrospective study (2018) (11)
- Eighteen‐ to 30‐year‐olds more likely to link to hepatitis C virus care: an opportunity to decrease transmission (2016) (11)
- Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug-Resistant Tuberculosis (XDR-TB) HIV Coinfection Treatment in KwaZulu-Natal, South Africa (2018) (11)
- Comparison of profile and treatment outcomes between elderly and non-elderly tuberculosis patients in Puducherry and Tamil Nadu, South India (2021) (11)
- Discordant rifampicin susceptibility results are associated with Xpert® MTB/RIF probe B and probe binding delay. (2019) (11)
- The complexity of diagnosing latent tuberculosis infection in older adults in long-term care facilities. (2016) (11)
- Effect of exposure to injection drugs or alcohol on antigen-specific immune responses in HIV and hepatitis C virus coinfection. (2007) (10)
- CD4 Recovery on Antiretroviral Therapy Is Associated With Decreased Progression to Liver Disease Among Hepatitis C Virus-Infected Injecting Drug Users (2015) (10)
- Clinical implications of recovery of Mycobacterium avium complex from the stool or respiratory tract of HIV-infected individuals. (1992) (10)
- Low body mass index and latent tuberculous infection: a systematic review and meta-analysis. (2018) (9)
- Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa (2015) (9)
- Partitioning the risk of tuberculosis transmission in household contact studies (2019) (9)
- Estimating the Relative Probability of Direct Transmission between Infectious Disease Patients (2019) (9)
- Clinical manifestations and epidemiology of adolescent tuberculosis in Ukraine (2020) (9)
- Editorial commentary: Treatment for multidrug-resistant tuberculosis: it's worse than we thought! (2014) (8)
- Encouraging news for multidrug-resistant tuberculosis treatment. (2010) (8)
- Latent Tuberculosis Infection Testing Practices in Long‐Term Care Facilities, Boston, Massachusetts (2017) (8)
- Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial. (2017) (8)
- Alcohol and Tobacco Use in a Tuberculosis Treatment Cohort during South Africa’s COVID-19 Sales Bans: A Case Series (2021) (8)
- Another step on the path to better TB therapies. (2002) (8)
- Isolation of Mycobacterium avium from Potable Water in Homes and Institutions of Patients with HIV Infection in Finland and the United States (2015) (7)
- Predictors of Loss to Follow-Up among Men with Tuberculosis in Puducherry and Tamil Nadu, India (2020) (7)
- Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting. (2018) (7)
- Reinfection with Mycobacterium tuberculosis. (2006) (7)
- Epidemiology of Human Disease Caused by Mycobacterium Avium Complex (1994) (7)
- Effectiveness of reporting on latent tuberculous infection in Massachusetts, 2006-2008. (2014) (6)
- Predictors of active injection drug use in a cohort of patients infected with hepatitis C virus. (2013) (6)
- Comparing tuberculosis gene signatures in malnourished individuals using the TBSignatureProfiler (2021) (6)
- Treatment for Multidrug-Resistant Tuberculosis: It ’ s Worse Than We Thought! (2014) (6)
- Seasonal drivers of tuberculosis: evidence from over 100 years of notifications in Cape Town. (2020) (6)
- Interleukin-2 production by persons with the generalized lymphadenopathy syndrome or the acquired immune deficiency syndrome (2004) (6)
- Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling. (2019) (6)
- Primary transmission of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected persons: what does the future hold in store? (2008) (6)
- Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency Virus (2020) (6)
- Mycobacterium avium complex and the acquired immunodeficiency syndrome. (1986) (5)
- Errors in reporting seropositivity for infection with human immunodeficiency virus (HIV) (1988) (5)
- Real-world Outcomes of Hepatitis C Treatment during the Interferon-free Era at an Urban Safety-net Hospital (2017) (5)
- Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk–Benefit Analysis (2017) (5)
- Clinical Liver Disease Progression Among Hepatitis C-Infected Drug Users With CD4 Cell Count Less Than 200 Cells/mm3 Is More Pronounced Among Women Than Men (2015) (5)
- A large, simple trial of a tuberculosis vaccine. (2000) (5)
- Household food insecurity among patients with pulmonary tuberculosis and its associated factors in South India: a cross-sectional analysis (2020) (5)
- Using cure models to estimate the serial interval of tuberculosis with limited follow-up. (2020) (5)
- Mycobacterial Infections in the Immunocompromised Host (1989) (5)
- Evaluation of an atypical HIV type 1 antibody. Serologic pattern leading to detection of HIV type 2 infection in North America. (1989) (4)
- HIV-2-Associated AIDS in the United States: The First Case (1989) (4)
- Optimizing MDR-TB clinical trials: insights from the first global MDR-TB Clinical Trials Landscape Meeting. (2016) (4)
- Acceptance of interferon-gamma release assay by a high-risk urban cohort. (2011) (4)
- Improved Survival for Patients with Extensively Drug Resistant Tuberculosis and HIV in South Africa. (2009) (4)
- Mycobacterium avium Complex (2015) (4)
- What it takes to control tuberculosis. (1998) (3)
- Pediatric Multidrug-resistant Tuberculosis in Kyiv City, Ukraine (2019) (3)
- Self-Reported Engagement in Care among U.S. Residents with Latent Tuberculosis Infection - 2011-2012. (2021) (3)
- Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis (2019) (3)
- Prognostic Indicators for Progression of HIV Disease (1992) (3)
- Alcohol use and tuberculosis clinical presentation at the time of diagnosis in Puducherry and Tamil Nadu, India (2020) (3)
- Quality of Hepatitis C Care at an Urban Tertiary Care Medical Center (2014) (3)
- Prevalence and risk factors associated with latent tuberculosis infection among household contacts of smear positive pulmonary tuberculosis patients in South India (2021) (3)
- Insights into drug-resistant tuberculosis treatment: results of The Union DR-TB Working Group Survey, 2017. (2018) (3)
- Changes in the virulence of Mycobacterium avium after passage through embryonated hens' eggs. (2000) (3)
- Altered immunity in hemophilia correlates with the presence of antibody to human T-cell lymphotropic virus type III (HTLV-III) (2004) (2)
- ‘People listen more to what actors say’: A qualitative study of tuberculosis-related knowledge, behaviours, stigma, and potential interventions in Puducherry, India (2021) (2)
- Nontuberculous Mycobacteria and Testing for Latent Tuberculosis Infection. (2018) (2)
- The Cost Effectiveness Of Tuberculin Skin Test And Interferon Gamma Release Assay Screening For Latent Tuberculosis Infection In The U.S (2011) (2)
- Current Rates Of Reactivation Tuberculosis In The United States (2011) (2)
- Incidence and Mortality of Extrapulmonary Tuberculosis in Ukraine: Analysis of National Surveillance Data. (2021) (2)
- Testing and treatment for latent tuberculosis infection in people living with HIV and substance dependence: a prospective cohort study (2022) (2)
- Trends, Mechanisms, and Racial/Ethnic Differences of Tuberculosis Incidence in the US-Born Population Aged 50 Years or Older in the United States (2021) (2)
- Impact of Choice of Test for Latent Tuberculosis Infection on Treatment Acceptance and Completion (2018) (2)
- Rethinking Public Private Mix (PPM) Performance in the Tuberculosis Program: How Is Care Seeking Impacting This Model in High TB Burden Countries? (2022) (2)
- Shortened Tuberculosis Treatment for People with HIV in South Africa: A Model-based Evaluation and Cost-effectiveness Analysis. (2020) (2)
- Brief Report: Assessing the Association Between Changing NRTIs When Initiating Second-Line ART and Treatment Outcomes (2017) (2)
- Prevalence and factors associated with diabetes mellitus among tuberculosis patients in South India—a cross-sectional analytical study (2021) (2)
- Tuberculosis—Learning the Impact of Nutrition (TB LION): protocol for an interventional study to decrease TB risk in household contacts (2021) (2)
- Estimation of the generation interval using pairwise relative transmission probabilities. (2021) (2)
- Greater preexisting interferon γ responses to mycobacterial antigens and lower bacillary load during HIV-associated tuberculosis. (2013) (2)
- Antibiotics and fecundability among female pregnancy planners: a prospective cohort study. (2021) (2)
- Nutritional Supplementation Would Be Cost-Effective for Reducing Tuberculosis Incidence and Mortality in India: The Ration Optimization to Impede Tuberculosis (ROTI-TB) model. (2021) (2)
- Risk factors for death during treatment in pulmonary tuberculosis patients in South India: A cohort study. (2020) (2)
- Discordance between Tuberculin Skin Test and Interferon Gamma Release Assayis Associated with Previous Latent Tuberculosis Infection Treatment (2016) (2)
- Buruli Ulcer: Review of a Reemerging Mycobacterial Disease (1999) (2)
- Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the Tunnel (2022) (2)
- Reasons For Non-Acceptance Of Latent Tuberculosis Infection (LTBI) Treatment; A Prospective Cohort Study In U.S. And Canada (2011) (2)
- Latent Tuberculosis Infection (2017) (1)
- What Can Genetic Relatedness Tell Us About Risk Factors for Tuberculosis Transmission? (2021) (1)
- Has compassionate use ever sunk a drug? (2018) (1)
- T1009 Use of a Death Adjudication Committee in a Cohort Study of Hepatitis C and HIV Infection (2008) (1)
- Overestimation of coprevalent and underestimation of incident tuberculosis in close contacts. (2015) (1)
- Effect of subspecialty training and experience on agreement with HIV guidelines (1997) (1)
- Accuracy of Timika X-ray scoring system to predict the treatment outcomes among tuberculosis patients in India. (2021) (1)
- Periconceptional antibiotic use and spontaneous abortion: A prospective cohort study. (2022) (1)
- Progress in global rollout of new multidrug-resistant tuberculosis treatments. (2019) (1)
- Tularemia in the United States, 1990-2000 (2002) (1)
- Evaluation of factors influencing Mycobacterium tuberculosis complex recovery and contamination rates in MGIT960. (2020) (1)
- Epidemiological approach to ending tuberculosis in high-burden countries (2022) (1)
- Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion (2022) (1)
- Attrition from HIV care among youth initiating ART in youth‐only clinics compared with general primary healthcare clinics in Khayelitsha, South Africa: a matched propensity score analysis (2022) (1)
- Development and validation of a parsimonious TB gene signature using the digital NanoString nCounter platform. (2022) (1)
- Immunologic evaluation of persons infected with human immunodeficiency virus. (1989) (1)
- A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients (1999) (1)
- Sustained reduction in tuberculosis incidence following a community-based participatory intervention. (2012) (1)
- Walter Werner Holland, 1929-2018. (2018) (1)
- 2570. HCV Screening Practices Among Adolescents and Young Adults in a National Sample of Federally Qualified Health Centers in the United States (2018) (1)
- Tuberculosis (2014) (1)
- Predictors of treatment for hepatitis C virus (HCV) infection in drug users. (2008) (1)
- The contribution of reinfection to annual rate of tuberculosis infection (ARI) and incidence of TB disease. (2022) (1)
- CD 4 Recovery on Antiretroviral Therapy Is Associated With Decreased Progression to Liver Disease Among Hepatitis C Virus-Infected Injecting Drug Users (2015) (1)
- Missed Tuberculosis Diagnoses: Analysis of Pediatric Autopsy Data From General Hospitals in Lviv, Ukraine. (2022) (1)
- The MDR-TB epidemic—a status report (2019) (1)
- Multidrug Resistant and Extensively Drug Resistant Tuberculosis among South African Health Care Workers. (2009) (1)
- Models for Pathogenesis of Mycobacterium avium (1996) (1)
- Progress in the roll-out of multidrug-resistant tuberculosis (MDR-TB) treatments. (2020) (0)
- Evidence-based prevention of MDR-TB: an intervention whose time has come. (2010) (0)
- Survival of people with untreated tuberculosis: effects of time, geography and setting (2022) (0)
- The Cost-Effectiveness of Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings (2016) (0)
- Derivation of a parsimonious Tuberculosis gene signature using the digital NanoString nCounter platform. (2022) (0)
- Mycobacterium avium-M. intracellulare and Acquired Immunodeficiency Syndrome (1987) (0)
- Attrition from Care Among Men Initiating ART in Male-Only Clinics Compared with Men in General Primary Healthcare Clinics in Khayelitsha, South Africa: A Matched Propensity Score Analysis (2022) (0)
- GUESTCOMMENTARY TheResurgence ofTuberculosis: IsYourLaboratory Ready? (1993) (0)
- Factors associated with screening failure and study withdrawal in multidrug-resistant TB. (2022) (0)
- Women Are At Increased Risk For Extensively Drug Resistant-tuberculosis (XDR-TB) In KwaZulu-Natal, South Africa (2010) (0)
- Tu1060 18-30 Year Olds More Likely to Link to HCV Care: An Opportunity to Decrease Transmission (2015) (0)
- At Long Last: Short, All-Oral Regimens for Multidrug-Resistant Tuberculosis in the United States (2023) (0)
- Recent Trends in Endocarditis (2002) (0)
- Gender and Drug-Resistant Tuberculosis in Nigeria (2023) (0)
- M. tuberculosis infection before, during and after pregnancy. (2023) (0)
- Risk for Hepatitis C Transmission from Healthcare Workers to Patients (2002) (0)
- Nutritional Supplementation Cost-Effectively Decreases Tuberculosis Incidence and Mortality in India: The Ration Optimization to Impede Tuberculosis (ROTI-TB) Model (2021) (0)
- Pertussis in the United States, 1997-2000 (2002) (0)
- Side Effects of Ciprofloxacin Prophylaxis for Anthrax Exposure (2001) (0)
- Current issues: hospital design qualities to facilitate healing. (1997) (0)
- De Novo Capreomycin Resistance Is Prevalent, Widespread, And Associated With Increased Early Mortality In Extensively Drug-Resistant Tuberculosis (XDR-TB) Patients In KwaZulu-Natal, South Africa (2012) (0)
- Reasons For Non-Completion Of Latent Tuberculosis Infection (LTBI) Treatment; A Prospective Cohort Study In The U.S. And Canada (2011) (0)
- Decreased Progression To Active Tuberculosis Following Re-Infection With M. Tuberculosis (2011) (0)
- Immunologic Functions and the Pathogenesis of the Acquired Immune Deficiency Syndrome (AIDS) (1985) (0)
- Epidemiologic Methods for Evaluating Architectural Design (2021) (0)
- Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement. (2023) (0)
- Moxifloxacin Improves TB Culture Conversion Rates Extensively Drug Resistant Tuberculosis (XDR-TB) Patients With And Without HIV Co-Infection (2011) (0)
- Burden of COPD Attributable to Tuberculosis: A Microsimulation Study. (2023) (0)
- Predictors of weight loss during the intensive phase of tuberculosis treatment in patients with drug-susceptible pulmonary tuberculosis in South India. (2022) (0)
- Preventive Strategies in Sexually Transmitted Diseases-Reply (1988) (0)
- Revisiting the Effectiveness of LTBI Screening in the U.S. (2009) (0)
- Directly Observed Therapy to Measure Adherence to Tuberculosis Medication in Observational Research: Protocol for a Prospective Cohort Study (Preprint) (2020) (0)
- Treatment Outcomes At 24 Months For Extensively Drug Resistant Tuberculosis (XDR-TB) With And Without HIV Co-infection (2010) (0)
- Genotyping indicates marked heterogeneity of tuberculosis transmission in the United States, 2009–2018 (2021) (0)
- Severe undernutrition in children affects tuberculin skin test performance in Southern India (2021) (0)
- Health-related quality of life and its effect on TB treatment outcomes. (2021) (0)
- Liver Disease among Hepatitis C Virus-infected Injecting Drug Users (2015) (0)
- ’ s response to reviews Title : Interaction of nutritional status and diabetes on active and latent tuberculosis : A crosssectional analysis (2019) (0)
- Randomized, controlled trial of a protein-calorie supplement for women coinfected with HIV-TB. (2022) (0)
- Malnutrition leads to increased inflammation and expression of tuberculosis risk signatures in recently exposed household contacts of pulmonary tuberculosis (2022) (0)
- Methods for handling missing data in serially sampled sputum specimens for mycobacterial culture conversion calculation (2022) (0)
- In reply. (2018) (0)
- Comparison of IGRA and TST in the diagnosis of latent tuberculosis among women of reproductive age in South India. (2022) (0)
- Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effective (2023) (0)
- Additional file 1: of Predictors of delayed care seeking for tuberculosis in southern India: an observational study (2017) (0)
- Effect of treatment adherence on the association between sex and unfavourable treatment outcomes among tuberculosis patients in Puducherry, India: a mediation analysis. (2022) (0)
- Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa (2022) (0)
- Increasing Drug Resistance Among Persons With Tuberculosis in Massachusetts, 2009–2018 (2020) (0)
- Reply to Swindells et al.: Trials of Tuberculosis-Preventive Therapy in People with HIV Infection (2020) (0)
- Acceptance of an Interferon-Gamma Release Assay for the Detection of Latent Tuberculosis Infection by a High Risk Cohort of Injection Drug Users. (2009) (0)
- Corrigendum: Malnutrition leads to increased inflammation and expression of tuberculosis risk signatures in recently exposed household contacts of pulmonary tuberculosis (2022) (0)
- Directly Observed Therapy to Measure Adherence to Tuberculosis Medication in Observational Research: Protocol for a Prospective Cohort Study (2021) (0)
- Challenging the management of drug-resistant tuberculosis – Authors' reply (2020) (0)
- MDR-TB in children: back to the basics. (2018) (0)
- Book Review Saving Sickly Children: The Tuberculosis Preventorium in American Life, 1909–1970 (Critical Issues in Health and Medicine.) By Cynthia A. Connolly. 182 pp., illustrated. New Brunswick, NJ, Rutgers University Press, 2008. $39.95. 978-0-8135-4267-6 (2009) (0)
- Candida glabrata: Risk Factors for an Emerging Pathogen (2002) (0)
- FDG-PET/CT activity leads to the diagnosis of unsuspected TB: a retrospective study (2018) (0)
- Global availability of susceptibility testing for second-line anti-tuberculosis agents. (2022) (0)
- Development of prognostic scoring system for predicting 1-year mortality among pulmonary tuberculosis patients in South India. (2022) (0)
- Prevalence And Incidence Of Latent Tuberculosis Infection Among HCV-infected Drug Users With The QuantiFERON-TB GOLD Test (2010) (0)
- Measuring adherence to tuberculosis medication in observational research: a DOT program for a prospective cohort study in Western Cape Province, South Africa (Preprint) (2020) (0)
- In reply to 'Completion of isoniazid preventive therapy and survival in HIV-infected TST-positive adults in Tanzania' [Correspondence]. (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Charles Robert Horsburgh?
Charles Robert Horsburgh is affiliated with the following schools:
